Lake Hospital System INC

Lake Hospital System INC was paid $56.46M by Medicaid between Jan 2018 and Dec 2024, across 456 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 19% of everything it billed.

33Billing provider infoLAKE HOSPITAL SYSTEM INC
WILLOUGHBY, OH 44094

33aNPI1972689172assigned 10/31/2006

33bProvider typePsychiatric Hospital Unit

28Total paid$56.46M

24GClaims1,256,024

24DCodes billed456

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Psychiatric Hospital Unit providers in Ohio

Rank by total paid#2 of 6

Median peer was paid$22.82M

This provider vs. median2.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	165,551	$5.83M
2019	161,220	$5.73M
2020	125,697	$6.92M
2021	135,928	$8.06M
2022	137,224	$7.31M
2023	313,998	$13.60M
2024incomplete	216,406	$9.01M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	19%	96,460	85,127	$10.47M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	11%	53,576	48,204	$6.02M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	9.5%	45,259	42,274	$5.34M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	8.6%	36,840	33,526	$4.84M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.4%	36,379	33,266	$4.75M
96361	Intravenous infusion, hydration; each additional hour	7.3%	15,349	13,495	$4.15M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	3.1%	25,285	20,473	$1.77M
70450	Computed tomography, head or brain; without contrast material	2.7%	6,071	5,273	$1.51M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	2.2%	12,518	11,460	$1.25M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	1.9%	10,497	9,834	$1.09M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.8%	3,913	3,288	$1.02M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.5%	11,958	4,366	$861K

444 more codes

80053	Comprehensive metabolic panel	1.2%	58,049	$661K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	1.1%	5,592	$595K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	2,831	$516K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,871	$438K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,465	$423K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	2,228	$404K
87631		<1%	2,577	$389K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,080	$363K
81514		<1%	2,432	$310K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	2,107	$302K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	2,626	$292K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	5,135	$276K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	2,242	$265K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,341	$258K
71275	Computed tomographic angiography, chest, with contrast material	<1%	846	$255K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	14,798	$209K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	1,799	$208K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	76,511	$202K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	13,203	$191K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	761	$184K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	911	$183K
84443	Thyroid stimulating hormone (TSH)	<1%	7,960	$179K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,682	$162K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	606	$147K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	1,371	$144K
80048	Basic metabolic panel (calcium, ionized)	<1%	16,501	$141K
36415	Collection of venous blood by venipuncture	<1%	81,462	$137K
G0378	Hospital observation service, per hour	<1%	2,776	$137K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	1,310	$125K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	4,101	$124K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	454	$119K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,262	$111K
71046	Radiologic examination, chest; 2 views	<1%	12,873	$104K
59025	Fetal non-stress test	<1%	575	$101K
76642		<1%	759	$99K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	981	$94K
99215	Doctor's office visit, returning patient (complex)	<1%	1,007	$93K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	5,172	$92K
90686		<1%	9,101	$91K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	595	$91K
20610		<1%	567	$91K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	31,355	$90K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	365	$88K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	338	$84K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	7,933	$82K
80320		<1%	5,554	$80K
80061	Lipid panel	<1%	5,279	$79K
97161		<1%	1,180	$77K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	438	$76K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,393	$74K
87086	Culture, bacterial; quantitative colony count, urine	<1%	14,468	$70K
97113		<1%	795	$65K
97162		<1%	1,097	$65K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,479	$65K
84484		<1%	16,233	$64K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	395	$61K
93307		<1%	257	$60K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	607	$59K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,522	$58K
90839		<1%	553	$58K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	1,318	$56K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	197	$54K
93975		<1%	394	$52K
83036	Hemoglobin; glycosylated (A1C)	<1%	5,867	$51K
76830	Ultrasound, transvaginal	<1%	1,268	$50K
71250		<1%	547	$49K
93971		<1%	700	$49K
81002		<1%	12,402	$48K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,827	$46K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	21,883	$44K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	2,165	$44K
90677		<1%	1,197	$43K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,250	$43K
87081		<1%	5,256	$41K
90670		<1%	6,087	$40K
87481		<1%	1,649	$39K
85027		<1%	5,114	$39K
86850		<1%	1,575	$39K
74018		<1%	719	$35K
81001		<1%	42,616	$32K
90715		<1%	2,268	$32K
90723		<1%	4,538	$31K
97014		<1%	875	$31K
76770		<1%	203	$31K
81003		<1%	11,612	$31K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	2,270	$31K
76536		<1%	248	$31K
12001		<1%	173	$30K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	1,624	$30K
71045	Radiologic examination, chest; single view	<1%	8,698	$30K
71271		<1%	161	$28K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	28,007	$27K
82607		<1%	1,008	$25K
86900		<1%	1,812	$25K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	9,193	$25K
97035		<1%	321	$25K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	817	$24K
90651		<1%	1,176	$24K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	184	$24K
70491		<1%	90	$24K
73030		<1%	1,063	$24K
11045		<1%	81	$23K
87150		<1%	360	$23K
90688		<1%	1,748	$22K
73630		<1%	1,159	$21K
73130		<1%	1,083	$21K
72110		<1%	393	$21K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,507	$21K
86592		<1%	486	$21K
99203	Doctor's office visit, new patient (routine)	<1%	150	$21K
90647		<1%	3,655	$18K
84702		<1%	2,187	$18K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	47	$18K
97165		<1%	288	$17K
73610		<1%	1,001	$17K
86140		<1%	1,376	$17K
90633		<1%	2,242	$17K
76801		<1%	562	$17K
84439		<1%	726	$17K
70486		<1%	351	$17K
96127		<1%	433	$16K
86803		<1%	628	$16K
82728		<1%	744	$15K
73564		<1%	907	$15K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	893	$14K
73221		<1%	59	$13K
73110		<1%	644	$13K
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	645	$13K
72050		<1%	231	$13K
73502		<1%	577	$12K
73562		<1%	224	$12K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,146	$12K
86038		<1%	284	$12K
81025		<1%	15,112	$11K
83550		<1%	892	$11K
83540		<1%	970	$11K
97116		<1%	688	$11K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	600	$11K
86762		<1%	406	$11K
93017		<1%	124	$11K
99385		<1%	143	$10K
96375	Therapeutic injection; each additional sequential IV push	<1%	17,555	$10K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	12	$10K
72100		<1%	961	$10K
95811		<1%	15	$10K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	109	$10K
72141		<1%	53	$10K
86901		<1%	1,812	$10K
77062		<1%	241	$10K
87800		<1%	735	$9K
73560		<1%	408	$9K
83970		<1%	269	$9K
87510		<1%	512	$9K
87077		<1%	844	$9K
76982		<1%	204	$9K
87340		<1%	526	$9K
83001		<1%	262	$8K
93970		<1%	72	$8K
99386		<1%	96	$8K
90734		<1%	1,045	$8K
83690		<1%	13,528	$8K
80069		<1%	458	$8K
92552		<1%	106	$8K
87480		<1%	512	$8K
94760		<1%	7,389	$8K
88341		<1%	60	$8K
90461		<1%	10,094	$7K
87205		<1%	1,437	$7K
82570		<1%	873	$7K
90716		<1%	587	$7K
88304		<1%	296	$6K
87660		<1%	514	$6K
85652		<1%	1,122	$6K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	624	$6K
87186		<1%	1,577	$6K
76000		<1%	42	$6K
84153		<1%	304	$6K
85610		<1%	4,345	$6K
90648		<1%	802	$6K
82550		<1%	917	$6K
82950		<1%	339	$6K
84403		<1%	269	$6K
80076		<1%	1,088	$6K
82947		<1%	3,694	$6K
96376		<1%	1,630	$6K
76775		<1%	43	$6K
84146		<1%	243	$6K
20611		<1%	19	$5K
12011		<1%	24	$5K
J1756	Injection, iron sucrose, 1 mg	<1%	160	$5K
90681		<1%	721	$5K
77080		<1%	80	$5K
90707		<1%	595	$5K
83605		<1%	2,637	$5K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,306	$4K
82043		<1%	454	$4K
86481		<1%	98	$4K
83735		<1%	3,071	$4K
83002		<1%	183	$4K
73140		<1%	173	$4K
83520		<1%	761	$4K
90680		<1%	840	$4K
83615		<1%	537	$4K
99152		<1%	553	$4K
72170		<1%	165	$4K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	39	$4K
90656		<1%	460	$4K
84550		<1%	395	$4K
90696		<1%	375	$4K
97166		<1%	142	$4K
87070		<1%	648	$4K
90472	Immunization administration, each additional vaccine (list separately)	<1%	1,414	$4K
96367		<1%	69	$3K
77061		<1%	102	$3K
90700		<1%	514	$3K
73590		<1%	233	$3K
82077		<1%	1,419	$3K
85014		<1%	329	$3K
77066	Tomosynthesis, mammo	<1%	297	$3K
73080		<1%	138	$3K
73090		<1%	169	$3K
97535	Self-care/home management training, each 15 minutes	<1%	112	$3K
84402		<1%	109	$3K
10060		<1%	16	$3K
86706		<1%	97	$3K
86431		<1%	126	$3K
87505		<1%	19	$3K
92060		<1%	57	$3K
J3490	Unclassified drugs	<1%	2,842	$2K
87147		<1%	443	$2K
77065	Tomosynthesis, mammo	<1%	232	$2K
90620		<1%	245	$2K
87641		<1%	53	$2K
85018		<1%	557	$2K
82746		<1%	259	$2K
85651		<1%	319	$2K
86787		<1%	84	$2K
82565		<1%	211	$2K
72131		<1%	31	$2K
82553		<1%	208	$2K
86160		<1%	105	$2K
86780		<1%	71	$2K
82627		<1%	46	$2K
85730		<1%	912	$2K
82805		<1%	285	$2K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	171	$2K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	14,577	$2K
90682		<1%	82	$2K
88342		<1%	61	$2K
97597		<1%	17	$2K
90710		<1%	300	$2K
83525		<1%	44	$2K
90662		<1%	254	$2K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	861	$1K
80332		<1%	71	$1K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	273	$1K
88307		<1%	36	$1K
84450		<1%	246	$1K
90832	Psychotherapy session, about 30 minutes	<1%	46	$1K
83655		<1%	40	$1K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	132	$1K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	415	$1K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	60	$1K
84460		<1%	260	$1K
86225		<1%	53	$1K
J7030	Infusion, normal saline solution , 1000 cc	<1%	13,091	$1K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	81	$1K
82248		<1%	291	$1K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	232	$1K
84703		<1%	1,131	$1K
85379		<1%	403	$1K
84132		<1%	361	$1K
87040		<1%	1,351	$1K
98925		<1%	26	$1K
86003		<1%	32	$1K
72072		<1%	64	$978.20
99153	Mod sedat endo service >5yrs	<1%	135	$971.29
99384		<1%	15	$960.19
86308		<1%	48	$955.99
84520		<1%	189	$952.22
80337		<1%	84	$858.78
80338		<1%	84	$858.78
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,899	$835.18
93880		<1%	15	$805.00
99406		<1%	28	$801.30
80074		<1%	26	$737.16
85007		<1%	266	$724.12
84156		<1%	130	$709.27
86364		<1%	22	$692.22
72114		<1%	13	$683.28
J1815	Injection, insulin, per 5 units	<1%	268	$649.71
87075		<1%	1,239	$618.85
82150		<1%	101	$612.85
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	1,150	$602.54
87634		<1%	89	$586.00
C1889	Implantable/insertable device, not otherwise classified	<1%	58	$571.27
76870		<1%	30	$552.36
A9270	Non-covered item or service	<1%	2,240	$541.58
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	433	$522.17
84100		<1%	126	$485.06
84165		<1%	32	$483.62
87563		<1%	12	$476.09
87430		<1%	440	$474.93
83880		<1%	1,101	$458.73
93296		<1%	31	$415.94
75774		<1%	14	$414.55
75716		<1%	13	$409.05
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,301	$395.71
C9113	Injection, pantoprazole sodium, per vial	<1%	214	$392.57
80143		<1%	1,000	$382.22
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	12	$366.20
83721		<1%	28	$354.00
83529		<1%	15	$351.85
J7120	Ringers lactate infusion, up to 1000 cc	<1%	2,773	$349.47
84480		<1%	16	$329.34
85300		<1%	549	$321.79
J1650	Injection, enoxaparin sodium, 10 mg	<1%	450	$306.06
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	15,497	$270.48
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	754	$267.84
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,615	$266.81
87210		<1%	49	$260.39
69209		<1%	76	$260.24
G0404	Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination	<1%	101	$217.91
90685		<1%	50	$217.50
J1644	Injection, heparin sodium, per 1000 units	<1%	1,093	$212.90
80361		<1%	139	$204.00
80354		<1%	121	$204.00
80347		<1%	13	$204.00
80326		<1%	13	$204.00
80360		<1%	13	$204.00
83992		<1%	13	$204.00
80356		<1%	13	$204.00
80377		<1%	13	$204.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	1,298	$200.73
80373		<1%	120	$187.00
76937		<1%	16	$182.84
Q3014	Telehealth originating site facility fee	<1%	90	$181.91
C1769	Guide wire	<1%	174	$159.53
80179		<1%	986	$155.38
87109		<1%	15	$139.80
J2060	Injection, lorazepam, 2 mg	<1%	860	$135.06
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	588	$130.96
J2704	Injection, propofol, 10 mg	<1%	2,465	$130.81
J7999	Compounded drug, not otherwise classified	<1%	170	$130.64
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	1,731	$127.49
80365		<1%	141	$126.40
80331		<1%	13	$126.40
80334		<1%	13	$126.40
80355		<1%	13	$126.40
80348		<1%	13	$126.40
80364		<1%	13	$126.40
80370		<1%	13	$126.40
80372		<1%	13	$126.40
80344		<1%	13	$126.40
80366		<1%	13	$126.40
80358		<1%	121	$126.40
80368		<1%	121	$126.40
80357		<1%	13	$126.40
80353		<1%	13	$126.40
80359		<1%	13	$126.40
80367		<1%	13	$126.40
80371		<1%	13	$126.40
80341		<1%	13	$126.40
J0780	Injection, prochlorperazine, up to 10 mg	<1%	528	$118.31
J3370	Injection, vancomycin hcl, 500 mg	<1%	164	$103.33
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,626	$99.29
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	486	$94.52
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	88	$85.07
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	3,620	$83.30
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	357	$76.54
J1630	Injection, haloperidol, up to 5 mg	<1%	489	$63.92
90474		<1%	168	$60.48
94664		<1%	20	$58.80
J8597	Antiemetic drug, oral, not otherwise specified	<1%	527	$53.02
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	529	$50.90
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	672	$47.34
72020		<1%	72	$44.49
J3360	Injection, diazepam, up to 5 mg	<1%	17	$43.76
J8540	Dexamethasone, oral, 0.25 mg	<1%	346	$38.12
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	990	$37.63
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	920	$36.69
J0690	Injection, cefazolin sodium, 500 mg	<1%	716	$34.70
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	313	$31.38
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	3,688	$29.19
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,178	$26.30
A4649	Surgical supply; miscellaneous	<1%	211	$23.56
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	54	$22.05
J3486	Injection, ziprasidone mesylate, 10 mg	<1%	17	$20.44
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	225	$20.20
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	19	$17.79
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	506	$17.34
J7050	Infusion, normal saline solution, 250 cc	<1%	434	$11.19
G0008	Administration of influenza virus vaccine	<1%	241	$10.30
J3475	Injection, magnesium sulfate, per 500 mg	<1%	83	$9.79
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	324	$7.64
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	110	$7.20
J3480	Injection, potassium chloride, per 2 meq	<1%	57	$6.80
J3411	Injection, thiamine hcl, 100 mg	<1%	23	$6.78
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	535	$6.40
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	35	$5.07
82962		<1%	148	$5.00
J1940	Injection, furosemide, up to 20 mg	<1%	39	$4.49
82330		<1%	111	$3.48
J2550	Injection, promethazine hcl, up to 50 mg	<1%	42	$3.26
J1171	Injection, hydromorphone, 0.1 mg	<1%	91	$2.43
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	211	$1.84
84295		<1%	92	$1.12
82435		<1%	93	$1.12
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	262	$1.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	54	$0.90
Q0244	Injection, casirivimab and imdevimab, 1200 mg	<1%	73	$0.52
90671		0%	97	$0.00
00840		0%	87	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	46	$0.00
J3372	Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg	0%	49	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	34	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	138	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	15	$0.00
80346		0%	111	$0.00
J7070	Infusion, d5w, 1000 cc	0%	29	$0.00
76942		0%	21	$0.00
82010		0%	14	$0.00
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	0%	12	$0.00
29125		0%	13	$0.00
01999		0%	12	$0.00
36416		0%	1,234	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	31	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	42	$0.00
76377		0%	289	$0.00
94761		0%	37	$0.00
80329		0%	50	$0.00
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	0%	73	$0.00
0011A		0%	60	$0.00
73060		0%	14	$0.00
72040		0%	15	$0.00
91301		0%	112	$0.00
0012A		0%	36	$0.00
82803		0%	18	$0.00
91303		0%	23	$0.00
A9698	Non-radioactive contrast imaging material, not otherwise classified, per study	0%	13	$0.00
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	0%	39	$0.00
0031A		0%	23	$0.00
95886		0%	13	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	32	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHRILLERO, ANTHONY (DIRECTOR OF FINANCIAL PLANNING)